Chimeric hepatitis E virus-like particle as a carrier for oral-delivery

Pitchanee Jariyapong, Li Xing, Nienke E. van Houten, Tian Cheng Li, Wattana Weerachatyanukul, Benjamin Hsieh, Carlos G. Moscoso, Chun Chieh Chen, Masahiro Niikura, Holland H R Cheng

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Oral delivery with virus-like particles (VLPs) is advantageous because of the inherited entry pathway from their parental viral capsids, which enables VLP to withstand the harsh and enzymatic environment associated with human digestive tract. However, the repeat use of this system is challenged by the self-immunity. In order to overcome this problem, we engineered the recombinant capsid protein of hepatitis E virus by inserting p18 peptide, derived from the V3 loop of HIV-1 gp120, into the antibody-binding site. The chimeric VLP resembled the tertiary and quaternary structures of the wild type VLP and specifically reacted with an HIV-1 antibody against V3 loop. Different from the wild type VLP, the chimeric VLP was vulnerable to trypsin cleavage although it appeared as intact particle, suggesting that the intermolecular forces of attraction between the recombinant capsid proteins are strong enough to maintain the VLP icosahedral arrangement. Importantly, this VLP containing the V3 loop did not react with anti-HEV antibodies, in correspondence to the mutation at its antibody-binding site. Therefore, the insertion of peptides at the surface antigenic site could allow VLPs to escape pre-existing anti-HEV humoral immunity.

Original languageEnglish (US)
Pages (from-to)417-424
Number of pages8
JournalVaccine
Volume31
Issue number2
DOIs
StatePublished - Jan 2 2013

    Fingerprint

Keywords

  • Hepatitis E virus
  • HIV-1 epitope
  • Quaternary structure
  • Recombinant capsid protein
  • Trypsin proteolysis
  • Virus like particle

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Jariyapong, P., Xing, L., van Houten, N. E., Li, T. C., Weerachatyanukul, W., Hsieh, B., Moscoso, C. G., Chen, C. C., Niikura, M., & Cheng, H. H. R. (2013). Chimeric hepatitis E virus-like particle as a carrier for oral-delivery. Vaccine, 31(2), 417-424. https://doi.org/10.1016/j.vaccine.2012.10.073